285 related articles for article (PubMed ID: 22446941)
21. The pathology of low-grade adenosquamous carcinoma of the breast. An immunohistochemical study.
Drudis T; Arroyo C; Van Hoeven K; Cordon-Cardo C; Rosen PP
Pathol Annu; 1994; 29 ( Pt 2)():181-97. PubMed ID: 7936747
[TBL] [Abstract][Full Text] [Related]
22. [Myoepithelial differentiation markers in salivary gland neoplasia].
Scarpellini F; Marucci G; Foschini MP
Pathologica; 2001 Dec; 93(6):662-7. PubMed ID: 11785118
[TBL] [Abstract][Full Text] [Related]
23. Quantitative expression study of four cytokeratins and p63 in squamous cell carcinoma of the tongue: suitability for sentinel node navigation surgery using one-step nucleic acid amplification.
Yamauchi K; Fujioka Y; Kogashiwa Y; Kohno N
J Clin Pathol; 2011 Oct; 64(10):875-9. PubMed ID: 21705376
[TBL] [Abstract][Full Text] [Related]
24. Metaplastic breast carcinomas and their relationship with basal-like phenotype.
Cakir A; Gönül II; Uluoğlu O
Turk Patoloji Derg; 2012; 28(2):134-41. PubMed ID: 22627631
[TBL] [Abstract][Full Text] [Related]
25. Use of p63 and CD10 in the differential diagnosis of papillary neoplasms of the breast.
de Moraes Schenka NG; Schenka AA; de Souza Queiroz L; de Almeida Matsura M; Vassallo J; Alvarenga M
Breast J; 2008; 14(1):68-75. PubMed ID: 18086274
[TBL] [Abstract][Full Text] [Related]
26. Cell blocks allow reliable evaluation of expression of basal (CK5/6) and luminal (CK8/18) cytokeratins and smooth muscle actin (SMA) in breast carcinoma.
Delgallo WD; Rodrigues JR; Bueno SP; Viero RM; Soares CT
Cytopathology; 2010 Aug; 21(4):259-66. PubMed ID: 19843143
[TBL] [Abstract][Full Text] [Related]
27. Immunohistochemical differentiation of atypical hyperplasia vs. carcinoma in situ of the breast.
Masood S; Sim SJ; Lu L
Cancer Detect Prev; 1992; 16(4):225-35. PubMed ID: 1281040
[TBL] [Abstract][Full Text] [Related]
28. Utility of immunohistochemical markers in irradiated breast tissue: an analysis of the role of myoepithelial markers, p53, and Ki-67.
Anderson K; Williams EM; Kaplan J; Matsumura L; Troxell ML
Am J Surg Pathol; 2014 Aug; 38(8):1128-37. PubMed ID: 25029119
[TBL] [Abstract][Full Text] [Related]
29. Necrotizing sialometaplasia versus invasive carcinoma of the head and neck: the use of myoepithelial markers and keratin subtypes as an adjunct to diagnosis.
Rizkalla H; Toner M
Histopathology; 2007 Aug; 51(2):184-9. PubMed ID: 17650214
[TBL] [Abstract][Full Text] [Related]
30. [A comparative evaluation of immunohistochemical markers for the differential diagnosis between malignant mesothelioma, non-small cell carcinoma involving the pleura, and benign reactive mesothelial cell proliferation].
Szczepulska-Wójcik E; Langfort R; Roszkowski-Sliz K
Pneumonol Alergol Pol; 2007; 75(1):57-69. PubMed ID: 17541913
[TBL] [Abstract][Full Text] [Related]
31. Phenotypic alterations in myoepithelial cells associated with benign sclerosing lesions of the breast.
Hilson JB; Schnitt SJ; Collins LC
Am J Surg Pathol; 2010 Jun; 34(6):896-900. PubMed ID: 20463570
[TBL] [Abstract][Full Text] [Related]
32. Subclassification of non-small cell lung carcinomas lacking morphologic differentiation on biopsy specimens: Utility of an immunohistochemical panel containing TTF-1, napsin A, p63, and CK5/6.
Mukhopadhyay S; Katzenstein AL
Am J Surg Pathol; 2011 Jan; 35(1):15-25. PubMed ID: 21164283
[TBL] [Abstract][Full Text] [Related]
33. Stromal keratin expression in phyllodes tumours of the breast: a comparison with other spindle cell breast lesions.
Chia Y; Thike AA; Cheok PY; Yong-Zheng Chong L; Man-Kit Tse G; Tan PH
J Clin Pathol; 2012 Apr; 65(4):339-47. PubMed ID: 22259180
[TBL] [Abstract][Full Text] [Related]
34. Observer variability in the histopathological reporting of core biopsies of papillary breast lesions is reduced by the use of immunohistochemistry for CK5/6, calponin and p63.
Douglas-Jones A; Shah V; Morgan J; Dallimore N; Rashid M
Histopathology; 2005 Aug; 47(2):202-8. PubMed ID: 16045782
[TBL] [Abstract][Full Text] [Related]
35. An immunohistochemical study of cervical neuroendocrine carcinomas: Neoplasms that are commonly TTF1 positive and which may express CK20 and P63.
McCluggage WG; Kennedy K; Busam KJ
Am J Surg Pathol; 2010 Apr; 34(4):525-32. PubMed ID: 20182342
[TBL] [Abstract][Full Text] [Related]
36. High-grade carcinomas of the breast showing patterns of mixed ductal and myoepithelial differentiation (including myoepithelial cell-rich carcinoma of the breast).
Coyne JD; Dervan PA; Barr L
Histopathology; 2004 Jun; 44(6):580-4. PubMed ID: 15186273
[TBL] [Abstract][Full Text] [Related]
37. Adenosquamous carcinoma: a report of nine cases with p63 and cytokeratin 5/6 staining.
Ko CJ; Leffell DJ; McNiff JM
J Cutan Pathol; 2009 Apr; 36(4):448-52. PubMed ID: 19278431
[TBL] [Abstract][Full Text] [Related]
38. Diagnostic use of cytokeratins, CD34, and neuronal cell adhesion molecule staining in focal nodular hyperplasia and hepatic adenoma.
Ahmad I; Iyer A; Marginean CE; Yeh MM; Ferrell L; Qin L; Bifulco CB; Jain D
Hum Pathol; 2009 May; 40(5):726-34. PubMed ID: 19157505
[TBL] [Abstract][Full Text] [Related]
39. Epithelial-myoepithelial carcinoma of the minor salivary glands: immunohistochemical and morphological features.
Angiero F; Sozzi D; Seramondi R; Valente MG
Anticancer Res; 2009 Nov; 29(11):4703-9. PubMed ID: 20032423
[TBL] [Abstract][Full Text] [Related]
40. Utility of high molecular weight cytokeratins, but not p63, in the differential diagnosis of neuroendocrine and basaloid carcinomas of the head and neck.
Serrano MF; El-Mofty SK; Gnepp DR; Lewis JS
Hum Pathol; 2008 Apr; 39(4):591-8. PubMed ID: 18284937
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]